Putting breakthrough health technologies and approaches within reach
Since 2002, PATH has worked in close partnership with the government of Uganda to address the country’s health needs—from our early work to prevent HIV/AIDS among youth and adolescents to our current comprehensive effort to reduce high rates of cervical cancer. Together, we have a strong track record of introducing new and improved health technologies and interventions to serve Ugandans’ needs.
Our work in cervical cancer is a prime example of our approach to solving health problems. Working with partners from both government and the private sector, we are tackling cervical cancer from every angle with a “toolkit of innovation.” This toolkit includes appropriate and affordable technologies and system and service innovations that, together, are improving prevention, detection, and treatment. Uganda is now a model for other countries trying to tackle this leading cause of cancer in African women.
Our work in Uganda
Technology introduction: PATH has evaluated dozens of health technologies in Uganda. We assess products and the factors needed for successful scale-up, such as feasibility, acceptability, supply chains, consumer demand, and policy environments. We introduce technologies and ensure they are adaptable and sustainable for local settings in collaboration with national and district health systems.
Family planning: PATH is leading the introduction of Sayana® Press, an innovative contraceptive that combines a lower-dose formulation of Depo-Provera® with the PATH-developed Uniject™ injection system. The prefilled injection system is easy to use and can be delivered by community health workers. We are also conducting research on self-injection.
Cervical cancer: PATH supported the scale-up of simple methods to screen and treat precancerous lesions, establishing these services in many of Uganda’s hospitals. We are now helping to institute a strong national cervical cancer screening program and supporting the African Regional Cervical Cancer Excellence Training Centre.
Vaccines and immunization: PATH helps to generate evidence for the introduction of new vaccines. Our initial cervical cancer work studied the optimal way to introduce the human papillomavirus (HPV) vaccine to protect young girls, and Uganda has since begun nationwide immunization. Now we are supporting the government’s decision-making process around malaria vaccine introduction. We also provide technical assistance for vaccine supply chain issues.
Advocacy for better health: PATH helps Ugandan citizens and civil society organizations improve the quality and availability of health and social services by enhancing their capacity to carry out effective advocacy. PATH’s advocacy efforts have also been instrumental in developing policy guidelines for product introduction and disease management.
Sayana Press and Depo-Provera are registered trademarks of Pfizer Inc. Uniject is a trademark of BD.
Photo: PATH/Will Boase.
The story of Sayana® Press
Sayana Press is increasing access and choice in Africa
How Uganda is beating cervical cancer—and lighting the way for the rest of Africa